Crinetics

Crinetics is a California-based pharmaceutical company that discovers develops and commercializes novel therapeutics for the treatment of rare endocrine diseases.

Business Model:

Revenue: $5.1M

Employees: 51-200

Detailed Crinetics Information

Geographic Data

Crinetics headquarters map

Address: 10222 Barnes Canyon Road

City: San Diego

State: CA

Zip: 92121

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$125M

Raised Total:

$446M

Metrics

2,413,949Website Global Rank

7,510Website Monthly Traffic

Twitter Followers

Description

Crinetics is a California-based pharmaceutical company that discovers develops and commercializes novel therapeutics for the treatment of rare endocrine diseases.

Contact Phone:
+18584506464

Contact Email:

Crinetics went public on 7/17/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/17/2018

IPO Valuation:
$391M

Ticker Symbol:
CRNX

IPO Price:
$17/share

Amount Raised:
$102M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2018 IPO $102M
10/2021 Post-IPO Equity $172.5M
1/2015 Grant $1.5M
4/2020 Post-IPO Equity $115.1M
7/2017 Grant 1 $2.8M National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
4/2015 Grant 1 $2.7M National Institute of Neurological Disorders and Stroke
National Institute of Neurological Disorders and Stroke
6/2018 Grant 1 $3.2M National Institutes of Health
National Institutes of Health
National Institutes of Health
National Institutes of Health
10/2015 Series A $18M 5AM Ventures
Versant Ventures
Vivo Capital
2/2009 Grant 1 - National Institutes of Health
National Institutes of Health
3/2018 Series B 6 $63.5M Versant Ventures
5AM Ventures
Perceptive Advisors
RA Capital Management
OrbiMed
Perceptive Advisors
Vivo Capital
Versant Ventures
5AM Ventures
Perceptive Advisors
RA Capital Management
OrbiMed
Perceptive Advisors
2/2018 Series B $60M Perceptive Advisors
RA Capital Management
OrbiMed
5AM Ventures
Versant Ventures
Vivo Capital
4/2014 Grant 1 - National Eye Institute
National Eye Institute
7/2021 Post-IPO Equity 1 $15M Frazier Healthcare Partners
Frazier Healthcare Partners
4/2022 Post-IPO Equity $125M
9/2013 Grant 1 $2.2M National Institutes of Health
National Institutes of Health
4/2021 Post-IPO Equity 3 $75M Bain Capital Life Sciences
Deep Track Capital
Driehaus Capital Management
Bain Capital Life Sciences
Deep Track Capital
Driehaus Capital Management
11/2015 Series A 3 $40M 5AM Ventures
Vivo Capital
Versant Ventures
5AM Ventures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research